JESSICA CHIODO: Open Payments
NPI 1922616796 · JOHNSTON, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,755 in 97 payments from 17 companies in 2025. Trend: 2023 $2,159 · 2024 $2,055 · 2025 $1,755
Food & beverage: $1,755
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 21 | $291 |
| Janssen Pharmaceuticals, Inc | 11 | $288 |
| Vanda Pharmaceuticals Inc. | 9 | $180 |
| ABBVIE INC. | 12 | $170 |
| Lundbeck LLC | 7 | $143 |
| MDD US Operations, LLC | 7 | $121 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $111 |
| E.R. Squibb & Sons, L.L.C. | 6 | $97 |
| Alkermes, Inc. | 4 | $75 |
| Corium, LLC | 3 | $70 |
Products named: REXULTI, SPRAVATO, FANAPT, VRAYLAR, Qelbree, CAPLYTA, COBENFY, ARISTADA.
Industry payments across IA — which companies pay providers there.
